Consistent with the incretin-mediated delivery of the PPAR// agonist, the metabolic effects of GLP-1GIPLani were blunted in DIO mice with pharmacological or genetic inhibition of GLP-1R, GIPR or PPAR, and vanished in double-incretin receptor knockout (DIR-KO) mice
Walker, T
The interesting back story to this award was to find out who were the scientists that recognized and pushed for its potential use for obesity
Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the Michigan Department of Health and Human Services, Placer.ai foot traffic data, public reporting by The Washington Post, and statements from companies including Taco Bell, Wendy's and Chipotle Mexican Grill
Neurobiology of depression: chronic stress alters the glutamatergic system in the BrainFocusing on AMPA receptor
The semaglutide dose escalation protocol and where 100 units fits Understanding where 100 units falls in the standard dose escalation schedule helps contextualize whether drawing 100 units makes sense for your protocol
